BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15688379)

  • 1. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma.
    Kondo S; Wakisaka N; Schell MJ; Horikawa T; Sheen TS; Sato H; Furukawa M; Pagano JS; Yoshizaki T
    Int J Cancer; 2005 Jun; 115(3):368-76. PubMed ID: 15688379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional polymorphism in the matrix metalloproteinase-1 gene promoter is associated with susceptibility and aggressiveness of head and neck cancer.
    O-charoenrat P; Leksrisakul P; Sangruchi S
    Int J Cancer; 2006 May; 118(10):2548-53. PubMed ID: 16353148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.
    Kim KR; Yoshizaki T; Miyamori H; Hasegawa K; Horikawa T; Furukawa M; Harada S; Seiki M; Sato H
    Oncogene; 2000 Mar; 19(14):1764-71. PubMed ID: 10777210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma.
    Horikawa T; Sheen TS; Takeshita H; Sato H; Furukawa M; Yoshizaki T
    Am J Pathol; 2001 Jul; 159(1):27-33. PubMed ID: 11438450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cross-talk between c-Jun/Ets1 involved in EB virus-encoded latent membrane protein 1 regulates expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma].
    Zeng L; Liu YP; Tao YG; Ai MD; Zhao XR; Cao Y
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):204-8. PubMed ID: 15949416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EB virus encoded latent membrane protein 1 mediated expression of transcription factor Ets-1 in nasopharyngeal carcinoma cells].
    Zeng L; Liu YP; Wang H; Tao YG; Zhao XR; Li W; Cao Y
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):454-7. PubMed ID: 15555331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
    Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P
    Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional repression of tissue inhibitor of metalloproteinase-3 by Epstein-Barr virus latent membrane protein 1 enhances invasiveness of nasopharyngeal carcinoma cells.
    Chang SH; Chang HC; Hung WC
    Oral Oncol; 2008 Sep; 44(9):891-7. PubMed ID: 18289921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients.
    Ben Nasr H; Chahed K; Remadi S; Zakhama A; Chouchane L
    Arch Med Res; 2009 Apr; 40(3):196-203. PubMed ID: 19427971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma.
    Codd JD; Salisbury JR; Packham G; Nicholson LJ
    J Pathol; 1999 Apr; 187(5):549-55. PubMed ID: 10398120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
    Wasil LR; Wei L; Chang C; Lan L; Shair KH
    J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capn4 is induced by and required for Epstein-Barr virus latent membrane protein 1 promotion of nasopharyngeal carcinoma metastasis through ERK/AP-1 signaling.
    Zheng P; Chen X; Xie J; Chen X; Lin S; Ye L; Chen L; Lin J; Yu X; Zheng M
    Cancer Sci; 2020 Jan; 111(1):72-83. PubMed ID: 31691433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.
    Chen CC; Liu HP; Chao M; Liang Y; Tsang NM; Huang HY; Wu CC; Chang YS
    Oncogene; 2014 Jul; 33(28):3648-59. PubMed ID: 23975427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
    Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
    Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells.
    Lo AK; Huang DP; Lo KW; Chui YL; Li HM; Pang JC; Tsao SW
    Int J Cancer; 2004 May; 109(6):919-25. PubMed ID: 15027126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
    Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
    Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1.
    Yoshizaki T
    Histol Histopathol; 2002; 17(3):845-50. PubMed ID: 12168795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.